Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Global Utilization and Registry Database for Improved Heart Preservation

NCT04141605 is registered in ClinicalTrials.gov with Paragonix Technologies as lead sponsor.

NCT NCT04141605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04141605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Global Utilization and Registry Database for Improved Heart Preservation
Lead sponsor
Paragonix Technologies
Phase
Observational
Overall status
Enrolling by invitation
Start date
February 14, 2020
Completion date
December 31, 2029
Enrollment
3,000 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

heart defects, congenital, heart diseases, heart failure